STEPHEN PAPPAS

Concepts (66)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatorenal Syndrome
12
2025
28
2.780
Why?
Vasoconstrictor Agents
11
2025
141
1.220
Why?
Lypressin
9
2025
17
0.970
Why?
Hepatitis B
1
2021
171
0.640
Why?
Duty to Warn
1
2019
2
0.610
Why?
Professional Impairment
1
2019
3
0.610
Why?
Alcoholic Intoxication
1
2019
11
0.600
Why?
Confidentiality
1
2019
106
0.570
Why?
Hepatitis C Antibodies
1
2017
24
0.550
Why?
Kidney Function Tests
2
2017
138
0.540
Why?
Alcoholism
1
2019
250
0.500
Why?
Diagnostic Tests, Routine
1
2017
132
0.500
Why?
Hepacivirus
1
2017
272
0.480
Why?
Albumins
6
2023
95
0.440
Why?
Liver Cirrhosis
5
2023
898
0.240
Why?
Acute Kidney Injury
2
2025
670
0.240
Why?
Bradycardia
1
2025
60
0.230
Why?
Liver Transplantation
3
2023
1102
0.210
Why?
Hepatitis, Alcoholic
1
2023
29
0.200
Why?
Respiratory Insufficiency
2
2022
247
0.190
Why?
Hepatitis B Antibodies
1
2021
24
0.180
Why?
Arrhythmias, Cardiac
1
2025
479
0.180
Why?
Hepatitis B Vaccines
1
2021
45
0.180
Why?
Acute-On-Chronic Liver Failure
1
2022
78
0.170
Why?
Hepatitis B virus
1
2021
140
0.170
Why?
Liver Cirrhosis, Alcoholic
1
2019
40
0.150
Why?
Safety
1
2019
216
0.140
Why?
Hepatic Encephalopathy
1
2019
84
0.140
Why?
Humans
16
2025
132081
0.130
Why?
Drug Therapy
1
2017
87
0.130
Why?
Health Personnel
1
2021
545
0.130
Why?
Alcohol Drinking
1
2019
356
0.120
Why?
Self Report
1
2019
553
0.120
Why?
Patient Education as Topic
1
2019
462
0.120
Why?
Surgical Procedures, Operative
1
2017
192
0.120
Why?
Interdisciplinary Communication
1
2016
133
0.110
Why?
Systemic Inflammatory Response Syndrome
1
2016
198
0.110
Why?
Interprofessional Relations
1
2016
156
0.110
Why?
Hepatitis C
1
2017
387
0.100
Why?
Information Dissemination
1
2016
200
0.100
Why?
Metabolomics
1
2017
479
0.100
Why?
Gastrointestinal Diseases
1
2016
356
0.090
Why?
Clinical Trials, Phase III as Topic
2
2025
84
0.090
Why?
Disease Progression
1
2017
2232
0.090
Why?
Renal Replacement Therapy
2
2023
158
0.080
Why?
Treatment Outcome
6
2023
13015
0.080
Why?
Biomarkers
1
2019
3404
0.080
Why?
Physicians
1
2016
637
0.080
Why?
Double-Blind Method
2
2021
1653
0.060
Why?
Randomized Controlled Trials as Topic
2
2025
1249
0.060
Why?
Middle Aged
6
2025
28980
0.060
Why?
Canada
2
2016
337
0.060
Why?
Drug Therapy, Combination
2
2017
1177
0.050
Why?
Infusions, Intravenous
1
2021
547
0.040
Why?
Male
6
2025
64952
0.040
Why?
Female
6
2025
70699
0.040
Why?
Aged
3
2025
21456
0.040
Why?
Combined Modality Therapy
1
2021
1294
0.030
Why?
Placebos
1
2016
235
0.030
Why?
Survival Rate
1
2020
2192
0.030
Why?
Adult
3
2025
31558
0.030
Why?
Survival Analysis
1
2016
1571
0.020
Why?
Prognosis
1
2020
5013
0.020
Why?
Kidney
1
2016
1338
0.020
Why?
United States
1
2016
11652
0.010
Why?
Retrospective Studies
1
2016
17367
0.010
Why?
PAPPAS's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (66)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_